Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07335484 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Aquarius Pilot Study to Evaluate the New Axonics Trial System

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 32 days later Sep 2026 → Nov 2026
See other at-risk trials from Axonics, Inc.

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 3 to 5
    • Eligibility criteria expanded, about 7 words
  2. Primary completion pushed from Sep 2026 to Nov 2026
    • Site details revised at 1 of 3 sites
    v9
  3. Study sites: 2 to 3v8
  4. Re-verified, no change to tracked fieldsv7
  5. Study sites: 1 to 2v6
  6. Recruitment opened
    • Study sites: 0 to 1
    • Start date changed from estimate of Apr 2026 to Apr 30, 2026
    v5
  7. Re-verified, no change to tracked fieldsv4
  8. Start date: Feb 2026 to Apr 2026v3
  9. Collaborators shortened, about 4 wordsv2
  10. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Axonics, Inc.
5 trials monitored
See 1 trial at risk
Evaluation of the new Axonics External Trial System (ETS-02) in patients with overactive bladder (OAB) and/or fecal incontinence (FI).
Trial Details
NCT Number NCT07335484
Lead Sponsor Axonics, Inc.
Conditions
(from sponsor)		 Urinary Urge Incontinence (UUI), Urinary Frequency (UF), Fecal Incontinence (FI), Overactive Bladder (OAB)
Related terms Fecal Incontinence, Urinary Bladder, Overactive, Urinary Incontinence, Urge
Enrollment 75 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov